News & Publications

November 6, 2019

Treventis attends BioPort Atlantic Conference

Treventis CEO Christopher Barden attended BioPort, Atlantic Canada’s largest health and life sciences event in Halifax, Nova Scotia. BioPort is...
Read More
November 6, 2019

Treventis gives invites presentation at Texas Life Science Forum

Treventis CSO Mark Reed attended the Texas Life Science Forum on November 7th in Houston, Texas, an event that brought...
Read More
October 27, 2019

Treventis attends the 2nd Neuromuscular Drug Development Summit (NMD)

CEO Christopher Barden attended the NMD Summit in Boston, Massachusetts, where he spoke with therapeutic and diagnostic companies that are...
Read More
October 24, 2019

Treventis scientists visit Society for Neuroscience conference

Treventis was represented at the 50th Society for Neuroscience Conference in Chicago, Illinois, one of the world’s largest conferences dedicated...
Read More
September 18, 2019

Treventis CEO invited speaker, panelist at XV International Pharma Licensing Symposium

Treventis CEO Christopher Barden was honored to be an invited speaker at the XV International Pharma Licensing Symposium, running from...
Read More
September 18, 2019

Treventis attends 4th Zebrafish for Personalized & Precision Medicine Conference

Treventis was represented at the 4th Zebrafish for Personalized & Precision Medicine Conference, running from Sep 18-20, 2019, in Toronto,...
Read More